FIELD: medicine.
SUBSTANCE: present group of inventions relates to medicine, namely to pediatrics and neurology, and concerns the treatment of attention deficit hyperactivity disorder (ADHD). For this purpose, a diamine oxidase (DAO) activity level in a subject's plasma is predetermined. If the diamine oxidase (DAO) activity level is below the threshold of 80 HDU/ml, an effective amount of DAO is administered.
EFFECT: this provides an effective treatment of ADHD by reducing the histamine level in the body of a subject.
16 cl, 7 ex, 3 tbl
Authors
Dates
2018-07-05—Published
2013-04-18—Filed